Specialties

To wrap up this series, we present the final two installments of the conversation between Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman. In part 5, Steve learns more about the institute founded and led by Dr. Bergman at Cedars-Sinai. In part 6, Steve asks what is more important — blood pressure or blood glucose levels?

In this week's Homerun Slides, the vicious circle of hyperinsulinemia in patients with type 2 diabetes.

Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman discuss his ADA presentations — the relationship between diabetes and altitude, and the role of kidneys in diabetes research. Steve also asks why the degredation of insulin in the liver is important in the pathogenesis of diabetes. Dr. Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

In this week's Homerun Slides, we begin a new series on the role of anti-diabetes medications in reducing cardiovascular risk and outcomes in diabetes patients.

A known link between low testosterone levels and decreased insulin sensitivity could lead to a treatment for men with type 2.

Evidence shows cardio-protective ability beyond glucose-lowering mechanism of action.

Diabetes patients tend to overestimate complications risk, treatment benefits.

In the Look AHEAD study, about 15% had symptoms of mild–moderate depression, about 17% were current users of antidepressant medication, and about 4% both [13]. Other studies in the USA have described higher rates, up to 25%, of more severe depression, with all ethnic groups (white, African-American, Latinos and others) recording similar rates.

Much of the literature concerns the important problem of type 2 diabetes and depression and, in comparison with type 1 diabetes, little about the psychological disturbances associated with specific phases of type 2 diabetes.

Study results indicate that risk increased similarly for all glucose lowering agents.